ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
about
Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.Endothelins and their receptors in cancer: identification of therapeutic targets.Expression patterns of endothelin-1 and its receptors in colorectal cancer.Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers.
P2860
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@en
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@nl
type
label
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@en
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@nl
prefLabel
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@en
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@nl
P2093
P2860
P1476
ETAR antagonist ZD4054 exhibit ...... vivo efficacy of anastrozole.
@en
P2093
Angela Brodie
Isabel Radke
Jeanett Fischgräbe
Luciana F Macedo
Ludwig Kiesel
Martin Smollich
Pia Wülfing
Shiuan Chen
P2860
P2888
P304
P356
10.1007/S10549-009-0644-2
P407
P50
P577
2009-11-27T00:00:00Z